Lieff Cabraser Civil Justice Blog

Lexi Hazam Elected Vice Chair of AAJ Torts

LJH AAJ Torts Vice Chair-blog image

Lieff Cabraser attorney Lexi J. Hazam was elected Vice Chair of the American Association for Justice’s (AAJ) Section on Toxic, Environmental and Pharmaceutical Torts (STEP). Promoting a fair and effective justice system, AAJ’s mission is to support the representation of those injured by the harmful misconduct and negligence of others. STEP is a section of the association, which focuses on pharmaceutical toxic effects, medical devices, pesticides, consumer products, industrial pollution, and other environmental damages.

A lawyer with global experience, Hazam is a partner in Lieff Cabraser’s San Francisco office and an emerging leader within the plaintiffs’ bar, representing clients in mass tort cases and qui tam actions, along with complex class actions.

Hazam has been appointed by the court overseeing the nationwide Benicar MDL litigation to the Plaintiffs’ Steering Committee, and serves as Co-Chair of the MDL Plaintiffs’ Science and Experts Committee.

Hazam also currently represents several hundred hip replacement patients in litigation over the DePuy ASR hip replacement (in which the firm has recovered over $30 million for its clients so far), the DePuy Pinnacle metal-on-metal hip device litigation, and the Stryker Rejuvenate implant cases.

Hazam has spoken at several conferences on Benicar injuries as well as the DePuy litigation. She has also spoken on mass torts topics at the Women En Mass conference for women in mass torts, the annual CAOC conference, and the California Lawyer’s Product Liability Roundtable.

Hazam’s qui tam cases include the $68 million settlement of litigation against Office Depot for overcharging California school districts and cities for school supplies; the $21.7 million settlement of litigation against Avaya, Lucent Technologies, and AT&T for charging governmental agencies for the lease of communications systems they no longer possessed; and several other cases alleging Medicare fraud.